Under the theme of ‘Colour of Innovation', Clariant Healthcare Polymer Solution experts explained how their deep technical and regulatory understanding can help medical device and pharmaceutical companies deliver a product that looks great, performs at the highest levels and readily meets regulatory requirements.“In the pharmaceutical packaging segment, it is not enough to create an attractive-looking product,” explains Steve Duckworth, global head of marketing and business development. “Your medical device and pharmaceutical packaging must meet all the rapidly changing regulatory requirements, while performing reliably over time. Applying Quality by Design (QbD) principles, we believe that every decision you make on plastic materials in the early development stages represents an opportunity to meet these challenges and make a truly exceptional product.”
At Pharmapack 2020, Clariant featured the following: (i) MEVOPUR ProTect, a new masterbatch offering a powerful oxygen barrier to meet long-term protection and regulatory requirements for pharmaceutical packaging; (ii) new polymer compounds showing how functionality – such as laser-welding, antistatic, improved scratch resistance, improved moisture barrier – can be designed into resins; and (iii) sustainability – continuing the theme of ‘Symphony of Collaboration’ from K2019 offering products and practical solutions for today and tomorrow to help companies make their healthcare products not only compliant but also sustainable.Introduced in 2010, the MEVOPUR product range celebrates 10 years of helping medical-device pharmaceutical companies reduce the risk of regulatory non-compliance throughout the product life cycle, while meeting the highest standards for performance and appearance. All MEVOPUR materials are produced in three dedicated EN:ISO13485-2016 registered facilities and have been pre-tested to ensure compliance with common standards.
For the latest refining and petrochemical industry related videos, subscribe to our YouTube page.